MÉTHODE DE TRAITEMENT GÉNÉTIQUE UTILISANT LE VIRUS AAV-XBP1S/GFP, ET SON UTILISATION DANS LA PREVENTION ET LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE
This invention presents the method and use of the AAV-XBPls/GFP virus, in the prevention and treatment of amyotrophic lateral sclerosis, as presented in the in vivo studies in figure 6/9.